ATRION 

$459.92
21
+$0.26+0.06% Tuesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
64.5
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Mar 26
$2.2
Dec 25
$2.2
Sep 25
$2.2
Jun 25
$2.2
Mar 25
$2.2
10Y Growth
5.4%
5Y Growth
-2.26%
3Y Growth
-8.8%
1Y Growth
-25%

Earnings

10MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
1.59
2.71
3.82
4.94
Expected EPS
N/A
Actual EPS
1.59

Financials

11.46%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
169.33MRevenue
19.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ATRI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a major player in the medical devices sector, directly competing with Atrion in areas such as cardiovascular and fluid delivery products.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes with Atrion in the cardiovascular market, offering similar medical devices and technologies.
Baxter International
BAX
Mkt Cap9.49B
Baxter International offers a range of medical devices and products that overlap with Atrion's portfolio, including fluid management and cardiovascular devices.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices division, competes across several of the same categories as Atrion, especially in surgical and cardiovascular products.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers medical devices in areas like cardiovascular, diabetes, and diagnostics, competing with Atrion's product lines.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company manufactures and sells medical devices that compete with Atrion's offerings, especially in the areas of infusion therapy and medication management.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew competes with Atrion in the medical devices market, particularly in surgical devices and wound care, areas where Atrion also operates.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the orthopedic and surgical products sector, areas relevant to Atrion's business interests.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation is a competitor in the medical technology field, offering products that compete with Atrion's in surgical and medical devices.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing with Atrion in the cardiovascular device market.

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Show more...
CEO
David A. Battat
Employees
712
Country
US
ISIN
US0499041053

Listings

0 Comments

Share your thoughts

FAQ

What is ATRION stock price today?
The current price of ATRI is $459.92 USD — it has increased by +0.06% in the past 24 hours. Watch ATRION stock price performance more closely on the chart.
What is ATRION stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ATRION stocks are traded under the ticker ATRI.
What were ATRION earnings last quarter?
ATRI earnings for the last quarter are 1.59 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ATRION revenue for the last year?
ATRION revenue for the last year amounts to 169.33M USD.
What is ATRION net income for the last year?
ATRI net income for the last year is 19.41M USD.
Does ATRION pay dividends?
Yes, ATRI dividends are paid quarterly. The last dividend per share was 2.2 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does ATRION have?
As of April 01, 2026, the company has 712 employees.
In which sector is ATRION located?
ATRION operates in the Other sector.
When did ATRION complete a stock split?
ATRION has not had any recent stock splits.
Where is ATRION headquartered?
ATRION is headquartered in Allentown, US.